Ark Invest, through its ARK Fintech Innovation ETF ARKF -5.46% + Free Alerts , bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s ...
EST Cathie Wood’s ARK Investment buys 171K shares of Beam Therapeutics (BEAM) todayDiscover the Best Stocks and Maximize Your Portfolio: ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
In addition to Twist Bioscience, ARK also increased its stake in Beam Therapeutics Inc (NASDAQ:BEAM) by acquiring a combined 47,127 shares across its ARKK and ARKG ETFs, valued at $1,526,914.
In collaboration with Hitachi, the National Cancer Centre Singapore has introduced Proton Beam Therapy - a treatment designed to target tumours with precision while reducing the impact on healthy ...
The Brighterside of News on MSN3d
New proton beam therapy precisely targets and destroys cancer cellsGlioblastoma, the most common and lethal form of primary brain cancer, presents daunting challenges. Each year, around 14,500 people in the United States face this aggressive disease. Its invasive ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback